ResMed (NYSE: RMD) has reported its plan to bring cloud connectivity and its remote patient monitoring software, AirView, to its Astral life support ventilators, increasing its global presence in numbers of remotely monitored patients, the company said.
ResMed currently has more than 2.5 million patients monitored through AirView.
Cloud connectivity will enable physicians and home medical equipment providers (HMEs) to access key patient data in the cloud to better manage and improve the outcomes of the thousands of patients who currently rely on Astral life support ventilators at home — all within ResMed´s secure, HIPAA-compliant cloud network. Clinicians will have the option of accessing the patient data via AirView or through the ResMed Data Exchange where they may integrate their own electronic medical records systems with AirView.
ResMed president of healthcare informatics, Raj Sodhi said, “Cloud connectivity is a major factor in the future of healthcare.”
Introduced in 2014, ResMed´s Astral life support ventilators offer mobility and ease of use for patients suffering from neuromuscular disease, chronic obstructive pulmonary disease (COPD), and other adult and pediatric respiratory disorders.
Select customers are currently piloting cloud connectivity on Astral devices; it´s expected to be available widely later this year.
ResMed offers medical devices and cloud-based software applications in connected care, with more than one million patients remotely monitored every day.